C. Scioscia
Impact in
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
- Systemic Lupus Erythematosus Research
- Eosinophilic Disorders and Syndromes
- Hematology top 10%
- Autoimmune and Inflammatory Disorders Research
Papers in ⓘ
- Rheumatology 21
- Rheumatoid Arthritis Research and Therapies 14
- Systemic Lupus Erythematosus Research 7
- Spondyloarthritis Studies and Treatments 6
-
- Psoriasis: Treatment and Pathogenesis 5
- Co-authors
- Giovanni Lapadula (25 shared papers)Florenzo Iannone (23 shared papers)Maria Grazia Anelli (15 shared papers)Michele Covelli (4 shared papers)Fabio Cacciapaglia (9 shared papers)Ignazio Grattagliano (1 shared paper)A. Rinaldi (2 shared papers)Vincenzo Patella (1 shared paper)
In The Last Decade
C. Scioscia
30 papers receiving 463 citations
Peers
Comparison fields: 5 of 81
- Rheumatology 310
- Hematology 99
- Immunology 142
- Hepatology 44
- Epidemiology 137
Countries citing papers authored by C. Scioscia
This map shows the geographic impact of C. Scioscia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Scioscia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Scioscia more than expected).
Fields of papers citing papers by C. Scioscia
This network shows the impact of papers produced by C. Scioscia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Scioscia. The network helps show where C. Scioscia may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Scioscia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Use of etanercept in the treatment of dermatomyositis: a case series. | 2006 | 78 |
| 2 | 2015 | 54 | |
| 3 | 2005 | 41 | |
| 4 | 2018 | 36 | |
| 5 | 2005 | 31 | |
| 6 | 2015 | 29 | |
| 7 | 2012 | 29 | |
| 8 | 2012 | 26 | |
| 9 | 2018 | 25 | |
| 10 | Repeated infusions of low-dose infliximab plus methotrexate in psoriatic arthritis: immediate benefits are not maintained after discontinuation of infliximab. | 2005 | 17 |
| 11 | 2013 | 15 | |
| 12 | 2016 | 14 | |
| 13 | 2016 | 14 | |
| 14 | 2014 | 13 | |
| 15 | Intentional etanercept use during pregnancy for maintenance of remission in rheumatoid arthritis. | 2011 | 11 |
| 16 | 2010 | 7 | |
| 17 | 2020 | 6 | |
| 18 | 2016 | 5 | |
| 19 | 2015 | 4 | |
| 20 | 2016 | 3 |
About C. Scioscia
C. Scioscia is a scholar working on Rheumatology, Immunology, Hematology, Epidemiology and Molecular Biology, having authored 32 papers that have together received 471 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (14 papers), Autoimmune and Inflammatory Disorders Research (8 papers), Systemic Lupus Erythematosus Research (7 papers), Spondyloarthritis Studies and Treatments (6 papers), Psoriasis: Treatment and Pathogenesis (5 papers), Chronic Lymphocytic Leukemia Research (3 papers), Systemic Sclerosis and Related Diseases (2 papers) and Electronic Health Records Systems (2 papers). The work is most often cited by research in Rheumatology (310 citations), Hematology (99 citations), Immunology (142 citations), Hepatology (44 citations) and Epidemiology (137 citations). C. Scioscia has collaborated with scholars based in Italy, Greece and Mexico. Frequent co-authors include Giovanni Lapadula, Florenzo Iannone, Maria Grazia Anelli, Michele Covelli, Fabio Cacciapaglia, Ignazio Grattagliano, A. Rinaldi, Vincenzo Patella, Cosimo De Bari and Giuseppe Lopalco. Their work appears in journals such as Annals of the Rheumatic Diseases, Scandinavian Journal of Rheumatology, Clinical Rheumatology, Journal of Clinical Medicine and Therapeutic Drug Monitoring.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.